FDA Import Refusal AEK-5388295-4/51/1 — Cadila Pharmaceuticals Limited
The FDA refused shipment AEK-5388295-4/51/1 from Cadila Pharmaceuticals Limited (India) on December 6, 2018. The refused product falls under Drugs and Biologics — DOMPERIDONE. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- December 6, 2018
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61TDY31 DOMPERIDONE
- Charges
- 75